Product
TXN10128
1 clinical trial
1 indication
Indication
Solid TumorsClinical trial
A Multicenter, Open-label, Phase 1 Dose Escalation and Expansion Study of TXN10128, an Inhibitor of ENPP1 in Subjects With Locally Advanced (Unresectable) or Metastatic Solid TumorsStatus: Recruiting, Estimated PCD: 2025-03-31